These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

160 related items for PubMed ID: 744

  • 21. Defect in insulin binding to receptors in obese man. Amelioration with calorie restriction.
    Archer JA, Gorden P, Roth J.
    J Clin Invest; 1975 Jan; 55(1):166-74. PubMed ID: 1109176
    [Abstract] [Full Text] [Related]

  • 22. Effects of age and obesity on insulin binding to isolated adipocytes.
    Olefsky JM, Reaven GM.
    Endocrinology; 1975 Jun; 96(6):1486-98. PubMed ID: 165063
    [Abstract] [Full Text] [Related]

  • 23. Polypeptide hormone receptor phosphorylation: is there a role in receptor-mediated endocytosis of human growth hormone?
    Asakawa K, Grunberger G, McElduff A, Gorden P.
    Endocrinology; 1985 Aug; 117(2):631-7. PubMed ID: 2990856
    [Abstract] [Full Text] [Related]

  • 24. Insulin receptor: role in the resistance of human obesity to insulin.
    Amatruda JM, Livingston JN, Lockwood DH.
    Science; 1975 Apr 18; 188(4185):264-6. PubMed ID: 164059
    [Abstract] [Full Text] [Related]

  • 25. Compartmentalization of human growth hormone by cultured human lymphocytes.
    Rosenfeld RG, Hintz RL.
    J Clin Endocrinol Metab; 1980 Aug 18; 51(2):368-75. PubMed ID: 6249840
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. [Diabetogenic role of obesity].
    Baranov VG, Zaripova ZKh, Alekseeva GG, Tikhonova NE.
    Klin Med (Mosk); 1981 Aug 18; 59(8):22-5. PubMed ID: 7026890
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Symposium I: hormone-fuel interactions in normal and diabetic man. The liver as site of insulin and glucagon action in normal, diabetic and obese humans.
    Felig P, Wahren J.
    Isr J Med Sci; 1975 Jun 18; 11(6):528-39. PubMed ID: 1099051
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Intracellular potassium depletion in IM-9 lymphocytes suppresses the slowly dissociating component of human growth hormone binding and the down-regulation of its receptors but does not affect insulin receptors.
    Ilondo MM, Courtoy PJ, Geiger D, Carpentier JL, Rousseau GG, De Meyts P.
    Proc Natl Acad Sci U S A; 1986 Sep 18; 83(17):6460-4. PubMed ID: 3018733
    [Abstract] [Full Text] [Related]

  • 34. Studies of insulin, growth hormone and prolactin binding: tissue distribution, species variation and characterization.
    Posner BI, Kelly PA, Shiu RP, Friesen HG.
    Endocrinology; 1974 Aug 18; 95(2):521-31. PubMed ID: 4369225
    [No Abstract] [Full Text] [Related]

  • 35. Circulating NSILA-s in man: Preliminary studies of stimuli in vivo and of binding to plasma components.
    Megyesi K, Kahn CR, Roth J, Gorden P.
    J Clin Endocrinol Metab; 1975 Sep 18; 41(3):475-84. PubMed ID: 169287
    [Abstract] [Full Text] [Related]

  • 36. Insulin receptor defect in insulin resistance: studies in the obese-hyperglycimic mouse.
    Kahn CR, Neville DM, Gorden P, Freychet P, Roth J.
    Biochem Biophys Res Commun; 1972 Jul 11; 48(1):135-42. PubMed ID: 5041873
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Receptor-binding and down-regulatory properties of 22000-Mr human growth hormone and its natural 20000-Mr variant on IM-9 human lymphocytes.
    Smal J, Closset J, Hennen G, de Meyts P.
    Biochem J; 1985 Jan 15; 225(2):283-9. PubMed ID: 2983666
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.